This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Gain a clear understanding of the time value of money. This concept is crucial for making informed financial decisions.
25,252 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...
Arista Networks stock flew higher on Friday, climbing more than 4% on a fresh analyst upgrade. This article breaks do...
A midweek surge in Calumet stock followed news of debt reduction, shining a light on how balance-sheet improvements c...
Institutional moves can hint at mood, but they don’t guarantee gains. A large stake in Capri Holdings by DME Capital ...
Peloton reports fresh restructuring amid a stubborn demand slump and rising costs. The destruction peloton continues ...
This article breaks down riskified (rskd) 2026 earnings, explaining what the latest results mean for growth, profitab...
Cerebras hit the market with fireworks, then cooled off quickly. This guide explains what happened, how to value the ...
A high-profile insider move shines a light on AI-driven demand for Willdan's engineering services. This piece breaks ...
A single bullish call can spark excitement, but savvy investors know that big upside ideas demand rigorous scrutiny. ...
Soleno's Q4 2025 earnings paint a picture of growth with new products and expanding margins. This guide breaks down t...